Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 6,250 shares at $40.00 ($250K) on 2020-08-06, disclosed to the SEC on 2020-08-07.
Open-market sale of $250k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |